However, limitations of our study, including the small number of participants in the available patient study groups, may be responsible for restricting putative correlations between CRFR1 and CRFR2 methylation levels and clinicopathological features such as tumor stage and metastasis. The gene discussed is CRHR2; the disease is neoplasm.